These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 34105432)

  • 1. Forty days of regulatory emergency use authorisation of COVID-19 vaccines: Interfacing efficacy, hesitancy and SDG target 3.8.
    Nhamo G; Sibanda M
    Glob Public Health; 2021 Oct; 16(10):1537-1558. PubMed ID: 34105432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs.
    Nhamo G; Chikodzi D; Kunene HP; Mashula N
    Glob Public Health; 2021 Mar; 16(3):319-339. PubMed ID: 33317389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. People's Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis.
    Eibensteiner F; Ritschl V; Nawaz FA; Fazel SS; Tsagkaris C; Kulnik ST; Crutzen R; Klager E; Völkl-Kernstock S; Schaden E; Kletecka-Pulker M; Willschke H; Atanasov AG
    J Med Internet Res; 2021 Apr; 23(4):e28973. PubMed ID: 33872185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using a low-cost, real-time electronic immunization registry in Pakistan to demonstrate utility of data for immunization programs and evidence-based decision making to achieve SDG-3: Insights from analysis of Big Data on vaccines.
    Siddiqi DA; Abdullah S; Dharma VK; Shah MT; Akhter MA; Habib A; Khan AJ; Chandir S
    Int J Med Inform; 2021 May; 149():104413. PubMed ID: 33652259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Vaccination in India: Considerations of Hesitancy and Bioethics in Global Health.
    Sarkar MA; Ozair A; Singh KK; Subash NR; Bardhan M; Khulbe Y
    Ann Glob Health; 2021; 87(1):124. PubMed ID: 34963880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Planning for COVID-19 vaccines safety surveillance.
    Kochhar S; Salmon DA
    Vaccine; 2020 Sep; 38(40):6194-6198. PubMed ID: 32684499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Vaccine Hesitancy among the Public in Kuwait: A Cross-Sectional Survey.
    Alibrahim J; Awad A
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) in patients with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society.
    Nojszewska M; Kalinowska A; Adamczyk-Sowa M; Kułakowska A; Bartosik-Psujek H
    Neurol Neurochir Pol; 2021; 55(1):8-11. PubMed ID: 33555604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency use authorisation of Covid-19 vaccines: An ethical conundrum.
    Vashishtha VM; Kumar P
    Indian J Med Ethics; 2021; VI(1):1-3. PubMed ID: 34080991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to Immunization: Rebuttal of Vaccine Hesitancy.
    Etzioni-Friedman T; Etzioni A
    Acta Haematol; 2021; 144(4):413-417. PubMed ID: 33202404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory concepts to guide and promote the accelerated but safe clinical development and licensure of COVID-19 vaccines in Europe.
    Wagner R; Meißner J; Grabski E; Sun Y; Vieths S; Hildt E
    Allergy; 2022 Jan; 77(1):72-82. PubMed ID: 33887070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer.
    Chen Y; Cheng L; Lian R; Song Z; Tian J
    Biosci Trends; 2021 May; 15(2):64-73. PubMed ID: 33746182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The VACCINES Act: Deciphering Vaccine Hesitancy in the Time of COVID-19.
    McAteer J; Yildirim I; Chahroudi A
    Clin Infect Dis; 2020 Jul; 71(15):703-705. PubMed ID: 32282038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating covid-19 vaccine efficacy and safety in the post-authorisation phase.
    Prugger C; Spelsberg A; Keil U; Erviti J; Doshi P
    BMJ; 2021 Dec; 375():e067570. PubMed ID: 34949587
    [No Abstract]   [Full Text] [Related]  

  • 17. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Vaccination Perception and Attitude among Healthcare Workers in Egypt.
    Fares S; Elmnyer MM; Mohamed SS; Elsayed R
    J Prim Care Community Health; 2021; 12():21501327211013303. PubMed ID: 33913365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Super-rapid race for saving lives by developing COVID-19 vaccines.
    Uttarilli A; Amalakanti S; Kommoju PR; Sharma S; Goyal P; Manjunath GK; Upadhayay V; Parveen A; Tandon R; Prasad KS; Dakal TC; Ben Shlomo I; Yousef M; Neerathilingam M; Kumar A
    J Integr Bioinform; 2021 Mar; 18(1):27-43. PubMed ID: 33761582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.
    Al-Maqbali JS; Al Rasbi S; Kashoub MS; Al Hinaai AM; Farhan H; Al Rawahi B; Al Alawi AM
    Am J Case Rep; 2021 Jun; 22():e932946. PubMed ID: 34117206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.